chronic thromboembolic pulmonary hypertensionpulmonary arterial hypertensionpulmonary endarterectomypulmonary hypertensionrisk stratification
Figures from the paper
Abstract (AI)
BACKGROUND: About 1% of adults suffer from pulmonary hypertension (PH). The various types of PH differ widely with respect to their incidence, clinical significance, and treatment. METHODS: Selective review of the literature in association with a consensus conference. RESULTS: Pulmonary hypertension is divided into five major categories. Those that are of particular clinical relevance are pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension due to left heart and lung diseases. Ten drugs from five different substance classes are now available for the treatment of PH and are often given in combination. The treatment strategy is determined by risk stratification based on the severity of disease, along with the clinical phenotype and possible accompanying illnesses. The preferred treatment for chronic thromboembolic pulmonary hypertension is surgical pulmonary endarterectomy; inoperable patients are treated with drugs and endovascular interventions. PH due to left heart and lung diseases generally calls for specific treatment of pulmonary hypertension only if there is severe right-heart strain. CONCLUSION: The diagnosis and treatment of severe forms of PH, in particular, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, are complex and are best carried out in close cooperation between the local physician and specialized centers.
Key Findings
1
Clinically important forms include pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and PH associated with left heart or lung diseases.
2
PH-specific treatment for disease caused by left heart or lung disease is generally indicated only when severe right-heart strain is present.
3
Pulmonary endarterectomy is the preferred treatment for chronic thromboembolic PH; inoperable patients receive pharmacological and endovascular therapies.
4
Pulmonary hypertension is classified into five major categories with substantial differences in incidence, clinical significance, and treatment.
5
Severe pulmonary arterial and chronic thromboembolic PH require coordinated management between local physicians and specialized centers.
6
Ten drugs from five substance classes are available for PH treatment, often used in combination according to risk stratification, clinical phenotype, and comorbidities.
Research Object
Pulmonary hypertension, including pulmonary arterial, chronic thromboembolic, left-heart- and lung-disease-associated forms
Research Subject
Classification, clinical significance, risk-based treatment strategies, and management of severe pulmonary hypertension
Publication Details
Publication Date
2017-02-03
Journal
Publisher
ISSN
Cited by
189
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest